{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:03:40Z","timestamp":1789956220818,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["2015-61X-15002"],"award-info":[{"award-number":["2015-61X-15002"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["2011-3514"],"award-info":[{"award-number":["2011-3514"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["2009-7053"],"award-info":[{"award-number":["2009-7053"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["2013-2838"],"award-info":[{"award-number":["2013-2838"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["K2009-61P-21304-04-4"],"award-info":[{"award-number":["K2009-61P-21304-04-4"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","award":["K2009-61X-21305-01-1"],"award-info":[{"award-number":["K2009-61X-21305-01-1"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bbi.2015.07.016","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T19:56:59Z","timestamp":1437163019000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms"],"prefix":"10.1016","volume":"51","author":[{"given":"Shahin","family":"Aeinehband","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-6144","authenticated-orcid":false,"given":"Philip","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"St\u00e5hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Engberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Jokinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8329-5219","authenticated-orcid":false,"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2015.07.016_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2015.07.016_b0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1468-1331.2005.01041.x","article-title":"Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients","volume":"12","author":"Amirkhani","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2015.07.016_b0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(88)90813-0","article-title":"The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection","volume":"90","author":"Andine","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2015.07.016_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/IJTR.S13256","article-title":"Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis","volume":"6","author":"Atlas","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.07.016_b0030","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","article-title":"Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl","volume":"128","author":"Behan","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2015.07.016_b0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","article-title":"Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor","volume":"154","author":"Birch","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2015.07.016_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(01)02017-0","article-title":"Oligodendrocyte killing by quinolinic acid in vitro","volume":"896","author":"Cammer","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.016_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/187152409787601941","article-title":"Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors","volume":"9","author":"Chen","year":"2009","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bbi.2015.07.016_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2015.07.016_b0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","article-title":"Natural history of multiple sclerosis: a unifying concept","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2015.07.016_b0070","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","article-title":"A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis","volume":"83","author":"Dickens","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2015.07.016_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbi.2015.07.016_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2015.07.016_b0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2015.07.016_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"The impact of fatigue on patients with multiple sclerosis","volume":"21","author":"Fisk","year":"1994","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2015.07.016_b0095","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1471-4159.1995.64031192.x","article-title":"Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis","volume":"64","author":"Flanagan","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2015.07.016_b0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.bjp.0706914","article-title":"Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain","volume":"149","author":"Grilli","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"Pt 5","key":"10.1016\/j.bbi.2015.07.016_b0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2015.07.016_b0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(89)90875-5","article-title":"Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites","volume":"489","author":"Kessler","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4137\/IJTR.S4294","article-title":"Understanding the roles of the kynurenine pathway in multiple sclerosis progression","volume":"3","author":"Lim","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.016_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2015.07.016_b0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"Mandi","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2015.07.016_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2015.07.016_b0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbi.2015.07.016_b0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2015.07.016_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bdi.12009","article-title":"Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder","volume":"14","author":"Olsson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2015.07.016_b0160","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0022-3565(24)37160-5","article-title":"Novel systemically active antagonists of the glycine site of the N-methyl-d-aspartate receptor: electrophysiological, biochemical and behavioral characterization","volume":"283","author":"Parsons","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2015.07.016_b0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/joim.12204","article-title":"A changing treatment landscape for multiple sclerosis: challenges and opportunities","volume":"275","author":"Piehl","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbi.2015.07.016_b0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.016_b0180","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1177\/1352458513500553","article-title":"Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis","volume":"19","author":"Ratzer","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2015.07.016_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2015.07.016_b0190","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2015.07.016_b0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-0270(97)00168-4","article-title":"Changes in blood\u2013brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue","volume":"79","author":"Reynolds","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbi.2015.07.016_b0200","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2015.07.016_b0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","article-title":"Quinolinic acid induces oxidative stress in rat brain synaptosomes","volume":"12","author":"Santamaria","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbi.2015.07.016_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington\u2019s disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2015.07.016_b0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2015.07.016_b0220","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2015.07.016_b0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.016_b0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2015.07.016_b0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"20","key":"10.1016\/j.bbi.2015.07.016_b0240","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.016_b0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0361-9230(00)00368-3","article-title":"Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin","volume":"53","author":"St\u2019astny","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2015.07.016_b0250","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood\u2013brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.016_b0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2015.07.016_b0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.1994.tb01480.x","article-title":"A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale","volume":"89","author":"Svanborg","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2015.07.016_b0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001756-200002070-00005","article-title":"Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain","volume":"11","author":"Tavares","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbi.2015.07.016_b0270","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbi.2015.07.016_b0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-2094-6-36","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer\u2019s disease","volume":"6","author":"Ting","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2015.07.016_b0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2015.07.016_b0285","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:41:07Z","timestamp":1760168467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159115004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":57,"alternative-id":["S0889159115004110"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}